Genetically reprogrammed HSV given systemically shrinks distant sarcomas
Wednesday, July 7, 2010 - 10:49
in Biology & Nature
Scientists have used a genetically reprogrammed herpes virus and an anti-vascular drug to shrink spreading distant sarcomas designed to model metastatic disease in mice - still an elusive goal when treating humans with cancer, according to a study in the July 8 Gene Therapy.